1. Home
  2. TDOC vs LQDA Comparison

TDOC vs LQDA Comparison

Compare TDOC & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TDOC
  • LQDA
  • Stock Information
  • Founded
  • TDOC 2002
  • LQDA 2004
  • Country
  • TDOC United States
  • LQDA United States
  • Employees
  • TDOC N/A
  • LQDA N/A
  • Industry
  • TDOC Medical/Nursing Services
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • TDOC Health Care
  • LQDA Health Care
  • Exchange
  • TDOC Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • TDOC 1.7B
  • LQDA 1.9B
  • IPO Year
  • TDOC 2015
  • LQDA 2018
  • Fundamental
  • Price
  • TDOC $8.63
  • LQDA $24.36
  • Analyst Decision
  • TDOC Buy
  • LQDA Strong Buy
  • Analyst Count
  • TDOC 17
  • LQDA 9
  • Target Price
  • TDOC $9.91
  • LQDA $32.67
  • AVG Volume (30 Days)
  • TDOC 10.1M
  • LQDA 2.2M
  • Earning Date
  • TDOC 10-29-2025
  • LQDA 11-03-2025
  • Dividend Yield
  • TDOC N/A
  • LQDA N/A
  • EPS Growth
  • TDOC N/A
  • LQDA N/A
  • EPS
  • TDOC N/A
  • LQDA N/A
  • Revenue
  • TDOC $2,528,199,000.00
  • LQDA $19,322,000.00
  • Revenue This Year
  • TDOC $0.06
  • LQDA $424.31
  • Revenue Next Year
  • TDOC $1.09
  • LQDA $359.32
  • P/E Ratio
  • TDOC N/A
  • LQDA N/A
  • Revenue Growth
  • TDOC N/A
  • LQDA 30.20
  • 52 Week Low
  • TDOC $6.35
  • LQDA $9.71
  • 52 Week High
  • TDOC $15.21
  • LQDA $29.94
  • Technical
  • Relative Strength Index (RSI)
  • TDOC 51.17
  • LQDA 55.89
  • Support Level
  • TDOC $7.96
  • LQDA $22.05
  • Resistance Level
  • TDOC $9.77
  • LQDA $24.34
  • Average True Range (ATR)
  • TDOC 0.63
  • LQDA 1.32
  • MACD
  • TDOC -0.05
  • LQDA 0.14
  • Stochastic Oscillator
  • TDOC 37.02
  • LQDA 82.99

About TDOC Teladoc Health Inc.

Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: